0001171843-26-001336.txt : 20260305 0001171843-26-001336.hdr.sgml : 20260305 20260305073029 ACCESSION NUMBER: 0001171843-26-001336 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20260305 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20260305 DATE AS OF CHANGE: 20260305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Compass Therapeutics, Inc. CENTRAL INDEX KEY: 0001738021 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39696 FILM NUMBER: 26724198 BUSINESS ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-500-8099 MAIL ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Olivia Ventures, Inc. DATE OF NAME CHANGE: 20180419 8-K 1 f8k_030326.htm FORM 8-K EX-99.1 2 exh_991.htm PRESS RELEASE EX-101.SCH 3 gnw-20250101.xsd XBRL SCHEMA FILE EX-101.DEF 4 gnw-20250101_def.xml XBRL DEFINITION FILE EX-101.LAB 5 gnw-20250101_lab.xml XBRL LABEL FILE EX-101.PRE 6 gnw-20250101_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT XML 9 Show.js IDEA: XBRL DOCUMENT XML 10 report.css IDEA: XBRL DOCUMENT XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT ZIP 15 0001171843-26-001336-xbrl.zip IDEA: XBRL DOCUMENT XML 16 f8k_030326_htm.xml IDEA: XBRL DOCUMENT